No medical condition is being investigated. This is a comparative bioavailability study. research hub

Comparative Bioavailability and Bioequivalence of Oxazepam 50 mg Orodispersible Tablets (Test) Versus Seresta® 50 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects

This study is comparing two versions of a 50mg oxazepam tablet: our new dissolving tablet and the existing Seresta® tablet. We want to see if the new tablet works in the body in a similar way to the old one. This helps us ensure it's safe and effective.